BPG is committed to discovery and dissemination of knowledge
Articles Published Processes
8/29/2014 5:40:00 PM | Browse: 849 | Download: 777
Publication Name World Journal of Clinical Cases
Manuscript ID 6806
Country/Territory Switzerland
Received
2013-10-29 11:03
Peer-Review Started
2013-10-29 20:56
To Make the First Decision
2013-11-19 12:56
Return for Revision
2013-11-19 15:59
Revised
2013-11-29 17:26
Second Decision
2013-12-19 13:01
Accepted by Journal Editor-in-Chief
Accepted by Company Editor-in-Chief
2013-12-19 13:27
Articles in Press
Publication Fee Transferred
Edit the Manuscript by Language Editor
2013-12-30 19:23
Typeset the Manuscript
2014-01-09 18:01
Publish the Manuscript Online
2014-01-16 15:24
ISSN 2307-8960 (online)
Open Access
Copyright
Article Reprints For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
Permissions For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
Publisher Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
Website http://www.wjgnet.com
Category Cardiac & Cardiovascular Systems
Manuscript Type Case Report
Article Title Left atrial thrombosis in an anticoagulated patient after bioprosthetic valve replacement: Report of a case
Manuscript Source Invited Manuscript
All Author List Gian Marco Rosa, Antonello Parodi, Ulrico Dorighi, Federico Carbone, François Mach, Alessandra Quercioli, Fabrizio Montecucco, Nicolas Vuilleumier, Manrico Balbi and Claudio Brunelli
Funding Agency and Grant Number
Funding Agency Grant Number
Swiss National Science Foundation 310030_118245
Swiss National Science Foundation 32003B_134963/1
Corresponding Author Fabrizio Montecucco, MD, PhD, Division of Cardiology, Department of Internal Medicine, Foundation for Medical Researches, University of Geneva, 6 viale Benedetto XV, 1211 Geneva, Switzerland. fabrizio.montecucco@unige.ch
Key Words Mitral valve; Thrombus; Prosthetic valve; Atrium; Hepatotoxicity
Core Tip Thromboembolism represents an important complication following heart valve replacement. This case report shows that although vitamin K antagonist (VKA) treatment represents the elective therapy in patients with left atrial thrombosis without mitral valve dysfunction, it may not be sufficient to avoid thrombogenesis. We also recommend that the discontinuation of VKA during the first three months after mitral valve surgery has to be carefully considered, especially in high thromboembolic risk patients.
Publish Date 2014-01-16 15:24
Citation Rosa GM, Parodi A, Dorighi U, Carbone F, Mach F, Quercioli A, Montecucco F, Vuilleumier N, Balbi M, Brunelli C. Left atrial thrombosis in an anticoagulated patient after bioprosthetic valve replacement: Report of a case. World J Clin Cases 2014; 2(1): 20-23
URL http://www.wjgnet.com/2307-8960/full/v2/i1/20.htm
DOI http://dx.doi.org/10.12998/wjcc.v2.i1.20
Full Article (PDF) wjcc-2-20.pdf
Full Article (Word) wjcc-2-20.doc
Manuscript File 6806-Review.doc
Answering Reviewers 6806-Answering reviewers.pdf
Copyright License Agreement 6806-Copyright assignment.pdf
Peer-review Report 6806-Peer review(s).pdf
Scientific Editor Work List 6806-Scientific editor work list.doc